Alpine Immune Sciences (ALPN) Misses Q4 EPS by 15c

Alpine Immune Sciences (NASDAQ: ALPN) reported Q4 EPS of ($0.41), $0.15 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $2.78 million versus the consensus estimate of $10.96 million.

For earnings history and earnings-related data on Alpine Immune Sciences (ALPN) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• The LGL Group (LGL) Misses Q2 EPS by 8c
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance